![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 2296-5262|32|5|260-262
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.32, Iss.5, 2009-04, pp. : 260-262
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The cost implications of prostate cancer screening in the Medicare population
CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Benefits and Risks of Prostate Cancer Screening
Oncology Research and Treatment, Vol. 37, Iss. 3, 2014-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prostate cancer and the PCP: the screening dilemma
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PSA screening and deaths from prostate cancer after diagnosis—a population based analysis
THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. :